Just like how preferred symbols will end in 'P', ADR
symbols on OTC Markets end in 'Y' to alert shareholders that they are an ADR
The primary objective of this study was to analyze the pattern of ADRs
and the drugs associated with it.
Furthermore, based on severity classification, Adverse drug reactions (ADRs
) were classified as mild (laboratory abnormality or symptoms not requiring treatment), moderate (laboratory abnormality or symptoms requiring treatment /admission to hospital or resulting in non-permanent disability), severe (laboratory abnormality or symptoms that were life threatening or resulted in permanent disability), and fatal (any ADR
that resulted in patient's death regardless and irrespective of the initial severity grading assessment)., The United States (US) Food and Drug Administration defines a serious adverse event as one when the patient outcome is one of the following:
Gastritis was the commonest ADR
seen in 8 patients (23.52%), followed by Weakness (17.64%).
In certain countries, the order continues, "demand for ADR
borrowing increased around dividend record dates so that certain tax-advantaged borrowers could, through a series of transactions, collect dividends without any tax withholding.
We determined suspected ADRs
cases according to the International Conference on Harmonisation (ICH), which defined a suspected ADR
as "any deviation of the expected clinical status (signs, symptoms and other clinical and laboratory findings)" (12).
Also, according to estimates, over 50 out of 1000 patients admitted in hospitals die due to ADRs
in the country.
Nawaz Sharif stated that ADR
complements the existing judicial system and helps the judiciary to focus on noncompoundable and other serious offences.
M2 EQUITYBITES-April 14, 2014--Citi named depositary for ADR
programme of Tarena
Out of these 257 patients, 8 (3.11%) had developed one or other ADRs
. However, further analysis showed that out of 160 male patients, 04 (2.5%) patients developed ADR
and out of the 97 female patients, 04 (4.12%) patients developed adverse drug reactions (p= 0.7218).
Clinicians treating TB patients around the world know these medicines well and are usually well aware of their associated adverse drug reactions (ADRs
These drugs are highly effective and their free distribution through the national programme may increase the risk of adverse drug reactions (ADRs
) and drug resistance.